Oramed Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021
Net Income	43.85	-19.06	5.53	-36.56	-35	-22.24
Depreciation & Amortization	0.12	0.19	0.2	0.06	0.05	0.08
Loss (Gain) From Sale of Assets	-	-	-	-0.01	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-	1.04
Loss (Gain) From Sale of Investments	-65.04	7.41	-16.39	0.76	0.22	-0.88
Stock-Based Compensation	4.94	4.05	4.22	11.53	5.33	2.7
Other Operating Activities	0.16	-4.21	-1.15	-2.75	-1.86	-0.56
Change in Accounts Payable	-0.18	3.53	-2.23	-0.38	2.07	2.06
Change in Unearned Revenue	-2.25	-	-1.34	-0.7	-2.71	-2.7
Change in Other Net Operating Assets	-0.12	-0.33	0.87	0.14	-1.45	-0.67
Operating Cash Flow	-10.59	-8.41	-10.3	-27.92	-33.37	-21.18
Capital Expenditures	-0.02	-0.02	-0.25	-0.5	-0.03	-0.38
Sale of Property, Plant & Equipment	-	-	-	0.02	-	-
Investment in Securities	25.51	105.9	-72.78	30.69	-297.72	1.61
Other Investing Activities	-0.07	-0.07	-	-0	-	-25
Investing Cash Flow	22.55	105.82	-73.04	30.21	-297.74	-23.76
Short-Term Debt Issued	-	-	99.55	-	-	-
Total Debt Issued	-	-	99.55	-	-	-
Short-Term Debt Repaid	-	-49.55	-50	-	-	-
Total Debt Repaid	-	-49.55	-50	-	-	-
Net Debt Issued (Repaid)	-	-49.55	49.55	-	-	-
Issuance of Common Stock	-	-	2.43	11.56	181.72	101.39
Repurchase of Common Stock	-1.93	-2.49	-	-0.78	-	-
Other Financing Activities	-	-	-	-	-	1.5
Financing Cash Flow	-1.93	-52.04	51.98	10.78	181.72	102.89
Foreign Exchange Rate Adjustments	0.04	-0	-0.05	-0.06	0.03	0
Net Cash Flow	10.08	45.37	-31.41	13.01	-149.37	57.95
Free Cash Flow	-10.61	-8.43	-10.55	-28.41	-33.39	-21.56
Free Cash Flow Margin	-530.40%	-	-787.24%	-1051.20%	-1231.31%	-797.48%
Free Cash Flow Per Share	-0.25	-0.21	-0.26	-0.73	-0.90	-0.76
Cash Interest Paid	-	2.32	0.57	-	-	-
Cash Income Tax Paid	3.32	-	-	0.1	0.3	-
Levered Free Cash Flow	-3.23	-1.51	-9.68	-15.75	-	-9.42
Unlevered Free Cash Flow	-3.23	-0.98	-8.41	-15.75	-	-9.42
Change in Working Capital	5.38	3.2	-2.7	-0.94	-2.1	-1.32

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.